BTN3A1 and cancer: In this study, 8 databases comprising 33 cancer types and 86 733 cases were accessed to analyze the expression, mutation, enrichment of related signal pathways of BTN3A1, and its relationship with immune cell infiltration and the prognosis of cancer patients.